Wilson Disease

Gastroenterology

Volumn 125, Issue 6, 2003, Pages 1868-1877

  Gitlin, Jonathan D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLAMINE; TETRATHIOMOLYBDIC ACID; TRIENTINE; ZINC ACETATE;

AUTOSOMAL RECESSIVE DISORDER; BILE FLOW; CHELATION THERAPY; CHROMOSOME 13; CLINICAL FEATURE; COPPER METABOLISM; DIAGNOSTIC TEST; DIET THERAPY; GENE LOCATION; GENETIC SCREENING; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SCREENING TEST; WILSON DISEASE;

EID: 0345059398     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.05.010     Document Type: Article

References (95)

1. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Lancet 1912;1:1115-1119.
2. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912;34:295-507.
3. Bramwell B. Familial cirrhosis of the liver: four cases of acute fatal cirrhosis of the liver in the same family, the patients being respectively nine, ten, fourteen and fourteen years of age-suggested relationship to Wilson's progressive degeneration of the lenticular nucleus. Edinb Med J 1916;17:90-99.
4. Cummings JN. The copper and iron content of the liver and brain in the normal and hepatolenticular degeneration. Brain 1948;71:410-417.
5. Scheinberg IH, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration. Science 1952;116:484-450.
6. Walshe JM. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 1956;21:487-492.
7. Bearn A. A genetical analysis of 30 families with Wilson disease. Ann Hum Genet 1960;24:33-39.
8. Frydman M, Bonne-Tamir B, Farrer LA, Conneally PM, Magazanik A, Ashbel S, Goldwitch Z. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci U S A 1985;82:1819-1821.
9. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, Devoto M, Peppercorn J, Bush AI, Sternlieb I, Pirastu M, Gusella JF, Evgrafov O, Penchaszadeh GK, Honig B, Edelman IS, Soares MB, Scheinberg IH, Gilliam TC. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:344-350.
10. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327-337.
11. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993;197:271-277.
12. Culotta VC, Gitlin JD. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The molecular and metabolic basis of inherited disease. New York Volume 3. New York: McGraw-Hill, 2001:3105-3136.
13. Tao TY, Gitlin JD. Hepatic copper metabolism: insights from genetic disease. Hepatology 2003;37:1241-1247.
14. Sternlieb I, Scheinberg IH. Radiocopper in diagnosing liver disease. Semin Nucl Med 1972;2:176-188.
15. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002;22:439-458.
16. Emre S, Atillasoy EO, Ozdemir S, Schilsky M, Rathna Varma CV, Thung SN, Sternlieb I, Guy SR, Sheiner PA, Schwartz ME, Miller CM. Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation 2001;72:1232-1236.
17. Gollan JL, Deller DJ. Studies on the nature and excretion of biliary copper in man. Clin Sci 1973;44:9-15.
18. Olivares M, Araya M, Uauy R. Copper homeostasis in infant nutrition: deficit and excess. J Pediatr Gastroenterol Nutr 2000;31:102-111.
19. Arrese M, Ananthananarayanan M, Suchy FJ. Hepatobiliary transport: molecular mechanisms of development and cholestasis. Pediatr Res 1998;44:141-147.
20. Gitlin JD. Aceruloplasminemia. Pediatr Res 1998;44:271-276.
21. Lee J, Prohaska JR, Thiele DJ. Essential role for mammalian copper transporter Ctrl in copper homeostasis and embryonic development. Proc Natl Acad Sci U S A 2001;98:6842-6847.
22. Kuo YM, Zhou B, Cosco D, Gitschier J. The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc Natl Acad Sci U S A 2001;98:6836-6841.
23. Klomp AE, Juijn JA, Van Der Gun LT, Van Den Berg IE, Berger R, Klomp LW. The N-terminus of the human copper transporter 1 (hCTR1) is localized extracellularly, and interacts with itself. Biochem J 2003;370:881-889.
24. Petris MJ, Smith K, Lee J, Thiele DJ. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J Biol Chem 2003;278:9639-9646.
25. Rae TD, Torres AS, Pufahl RA, O'Halloran TV. Mechanism of Cu,Zn-superoxide dismutase activation by the human metallochaperone hCCS. J Biol Chem 2001;276:5166-5176.
26. O'Halloran TV, Culotta VC. Metallochaperones, an intracellular shuttle service for metal ions. J Biol Chem 2000;275:25057-25060.
27. Huffman DL, O'Halloran TV. Function, structure, and mechanism of intracellular copper trafficking proteins. Annu Rev Biochem 2001;70:677-701.
28. Wernimont AK, Huffman DL, Lamb AL, O'Halloran TV, Rosenzweig AC. Structural basis for copper transfer by the metallochaperone for the Menkes/Wilson disease proteins. Nat Struct Biol 2000;7:766-771.
29. Larin D, Mekios C, Das K, Ross B, Yang AS, Gilliam TC. Characterization of the interaction between the Wilson and Menkes disease proteins and the cytoplasmic copper chaperone, HAH1p. J Biol Chem 1999;274:28497-28504.
30. Hamza I, Schaefer M, Klomp LW, Gitlin JD. Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis. Proc Natl Acad Sci U S A 1999;96:13363-13368.
31. Palmiter RD. The elusive function of metallothioneins. Proc Natl Acad Sci U S A 1998;95:8428-8430.
32. Kelly EJ, Palmiter RD. A murine model of Menkes disease reveals a physiological function of metallothionein. Nat Genet 1996;13:219-222.
33. Schaefer M, Gitlin JD. Genetic disorders of membrane transport. IV. Wilson's disease and Menkes disease. Am J Physiol 1999;276:G311-G314.
34. Lutsenko S, Petris MJ. Function and regulation of the mammalian copper-transporting ATPases: insights from biochemical and cell biological approaches. J Membr Biol 2003;191:1-12.
35. Hung IH, Suzuki M, Yamaguchi Y, Yuan DS, Klausner RD, Gitlin JD. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem 1997;272:21461-21466.
36. Schaefer M, Hopkins RG, Failla ML, Gitlin JD. Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver. Am J Physiol 1999;276:G639-G646.
37. van De Sluis B, Rothuizen J, Pearson PL, van Oost BA, Wijmenga C. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet 2002;11:165-173.
38. Payne AS, Gitlin JD. Functional expression of the Menkes disease protein reveals common biochemical mechanisms among the copper-transporting P-type ATPases. J Biol Chem 1998;273:3765-3770.
39. Moller JV, Juul B, Ie Maire M. Structural organization, ion transport, and energy transduction of P-type ATPases. Biochim Biophys Acta 1996;1286:1-51.
40. Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994;3:1647-1656.
41. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995;9:210-217.
42. Payne AS, Kelly EJ, Gitlin JD. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proc Natl Acad Sci U S A 1998;95:10854-10859.
43. Huster D, Hoppert M, Lutsenko S, Zinke J, Lehmann C, Mossner J, Berr F, Caca K. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines. Gastroenterology 2003;124:335-345.
44. Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998;28(Suppl 1):28-36.
45. Schilsky ML. Wilson disease: genetic basis of copper toxicity and natural history. Semin Liver Dis 1996;16:83-95.
46. Loudianos G, Gitlin JD. Wilson's disease. Semin Liver Dis 2000;20:353-364.
47. Cox DW, Moore SD. Copper transporting P-type ATPases and human disease. J Bioenerg Biomembr 2002;34:333-338.
48. Riordan SM, Williams R. The Wilson's disease gene and phenotypic diversity. J Hepatol 2001;34:165-171.
49. Forbes JR, Cox DW. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant? Am J Hum Genet 1998;63:1663-1674.
50. Forbes JR, Cox DW. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins. Hum Mol Genet 2000;9:1927-1935.
51. Tsivkovskii R, Efremov RG, Lutsenko S. The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B. J Biol Chem 2003;278:13302-13308.
52. Sokol RJ. Antioxidant defenses in metal-induced liver damage. Semin Liver Dis 1996;16:39-46.
53. Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, Mariani SM, Hack V, Stremmel W, Krammer PH, Galle PR. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 1998;4:588-593.
54. Schilsky ML. Diagnosis and treatment of Wilson's disease. Pediatr Transplant 2002;6:15-19.
55. Eide DJ, Bridgham JT, Zhao Z, Mattoon JR. The vacuolar H(+)-ATPase of Saccharomyces cerevisiae is required for efficient copper detoxification, mitochondrial function, and iron metabolism. Mol Gen Genet 1993;241:447-456.
56. Gaxiola RA, Yuan DS, Klausner RD, Fink GR. The yeast CLC chloride channel functions in cation homeostasis. Proc Natl Acad Sci U S A 1998;95:4046-4050.
57. Davis-Kaplan SR, Askwith CC, Bengtzen AC, Radisky D, Kaplan J. Chloride is an allosteric effector of copper assembly for the yeast multicopper oxidase Fet3p: an unexpected role for intracellular chloride channels. Proc Natl Acad Sci U S A 1998;95:13641-13645.
58. Pyeritz RE. Genetic heterogeneity in Wilson disease: lessons from rare alleles. Ann Intern Med 1997;127:70-72.
59. Li Y, Togashi Y, Sato S, Emoto T, Kang JH, Takeichi N, Kobayashi H, Kojima Y, Une Y, Uchino J. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J Clin Invest 1991;87:1858-1861.
60. Wu J, Forbes JR, Chen HS, Cox DW. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 1994;7:541-545.
61. Theophilos MB, Cox DW, Mercer JF. The toxic milk mouse is a murine model of Wilson disease. Hum Mol Genet 1996;5:1619-1624.
62. Coronado V, Nanji M, Cox DW. The Jackson toxic milk mouse as a model for copper loading. Mamm Genome 2001;12:793-795.
63. Buiakova OI, Xu J, Lutsenko S, Zeitlin S, Das K, Das S, Ross BM, Mekios C, Scheinberg IH, Gilliam TC. Null mutation of the murine ATPTB (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet 1999;8:1665-1671.
64. Brewer GJ. Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med 2000;223:39-46.
65. Walshe JM. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients. Q J Med 1989;70:253-263.
66. Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991;100:762-767.
67. McCullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, Dickson ER. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology 1983;84:161-167.
68. Davies SE, Williams R, Portmann B. Hepatic morphology and histochemistry of Wilson's disease presenting as fulminant hepatic failure: a study of 11 cases. Histopathology 1989;15:385-394.
69. Sternlieb I. Perspectives on Wilson's disease. Hepatology 1990;12:1234-1239.
70. Polio J, Enriquez RE, Chow A, Wood WM, Atterbury CE. Hepatocellular carcinoma in Wilson's disease. Case report and review of the literature. J Clin Gastroenterol 1989;11:220-224.
71. Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol 1991;238:281-287.
72. Oder W, Prayer L, Grimm G, Spatt J, Ferenci P, Kollegger H, Schneider B, Gangl A, Deecke L. Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology 1993;43:120-124.
73. Cartwright GE. Diagnosis of treatable Wilson's disease. N Engl J Med 1978;298:1347-1350.
74. Dening TR, Berrios GE. Wilson's disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989;46:1126-1134.
75. Dening TR. The neuropsychiatry of Wilson's disease: a review. Int J Psychiatry Med 1991;21:135-148.
76. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991;115:720-726.
77. Gitlin JD. Wilson's disease. In: Zakim D, Boyer TD, ed. Hepatology. Volume 2. Philadelphia: Saunders, 2002:1273-1287.
78. Schilsky ML, Sternlieb I. Overcoming obstacles to the diagnosis of Wilson's disease. Gastroenterology 1997;113:350-353.
79. Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med 1968;278:352-359.
80. Gibbs K, Walshe JM. A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. Q J Med 1979;48:447-463.
81. Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998;67:972S-977S.
82. Takahashi W, Yoshii F, Shinohara Y. Reversible magnetic resonance imaging lesions in Wilson's disease: clinical-anatomical correlation. J Neuroimaging 1996;6:246-248.
83. Butler P, McIntyre N, Mistry PK. Molecular diagnosis of Wilson disease. Mol Genet Metab 2001;72:223-230.
84. Sternlieb I. Wilson's disease and pregnancy. Hepatology 2000;31:531-532.
85. Scheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med 1987;317:209-213.
86. Walshe JM. Treatment of Wdson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982;1:643-647.
87. Brewer GJ, Hedera P, Kluin KJ, Carlson M, Askari F, Dick RB, Sitterly J, Fink JK. Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 2003;60:379-385.
88. Brewer GJ. Treatment of Wilson's disease with zinc. J Lab Clin Med 1999;134:322-324.
89. Schilsky ML. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation? Curr Gastroenterol Rep 2001;3:54-59.
90. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994;19:583-587.
91. Bellary S, Hassanein T, Van Thiel DH. Liver transplantation for Wilson's disease. J Hepatol 1995;23:373-381.
92. Schumacher G, Platz KP, Mueller AR, Neuhaus R, Steinmuller T, Bechstein WO, Becker M, Luck W, Schuelke M, Neuhaus P. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease. Clin Transplant 1997;11:217-224.
93. Schumacher G, Platz KP, Mueller AR, Neuhaus R, Luck W, Langrehr JM, Settmacher U, Steinmueller T, Becker M, Neuhaus P. Liver transplantation in neurologic Wilson's disease. Transplant Proc 2001;33:1518-1519.
94. Asonuma K, Inomata Y, Kasahara M, Uemoto S, Egawa H, Fujita S, Kiuchi T, Hayashi M, Tanaka K. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease. Pediatr Transplant 1999;3:201-205.
95. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003;37:1475-1492.